The global Kidney Cancer market is projected to grow from US$ 487.2 million in 2024 to US$ 703.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.

Kidney Cancer Market

Market Analysis and Insights: Global Kidney Cancer Market

Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Report Covers:

This report presents an overview of global market for Kidney Cancer market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Kidney Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Kidney Cancer revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Kidney Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Kidney Cancer revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Kidney Cancer Market Report

Report Metric	Details
Report Name	Kidney Cancer Market
Accounted market size in 2024	US$ 487.2 million
Forecasted market size in 2030	US$ 703.7 million
CAGR	6.3
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	Surgery Immunotherapy Targeted Therapy Other
Segment by Application	Renal Cell Carcinoma Renal Pelvis Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Kidney Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Cancer revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Kidney Cancer Market growing?

Ans: The Kidney Cancer Market witnessing a CAGR of 6.3 during the forecast period 2024-2030.

What is the Kidney Cancer Market size in 2030?

Ans: The Kidney Cancer Market size in 2030 will be US$ 703.7 million.

What is the market share of major companies in Kidney Cancer Market?

Ans: Global top four manufacturers hold a share over 35%.

What is the Kidney Cancer Market share by region?

Ans: North America has the largest number of Kidney cancer, holds a share of about 50%.

What is the Kidney Cancer Market share by type?

Ans: In terms of product, targeted therapy is the largest segment, with a share over 45%.

What is the Kidney Cancer Market share by application?

Ans: And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Who are the main players in the Kidney Cancer Market report?

Ans: The main players in the Kidney Cancer Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai

What are the Application segmentation covered in the Kidney Cancer Market report?

Ans: The Applications covered in the Kidney Cancer Market report are Renal Cell Carcinoma, Renal Pelvis Cancer, Other

What are the Type segmentation covered in the Kidney Cancer Market report?

Ans: The Types covered in the Kidney Cancer Market report are Surgery, Immunotherapy, Targeted Therapy, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Kidney Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Surgery

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.2.5 Other

1.3 Market by Application

1.3.1 Global Kidney Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Renal Cell Carcinoma

1.3.3 Renal Pelvis Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Kidney Cancer Market Perspective (2019-2030)

2.2 Global Kidney Cancer Growth Trends by Region

2.2.1 Kidney Cancer Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Kidney Cancer Historic Market Size by Region (2019-2024)

2.2.3 Kidney Cancer Forecasted Market Size by Region (2025-2030)

2.3 Kidney Cancer Market Dynamics

2.3.1 Kidney Cancer Industry Trends

2.3.2 Kidney Cancer Market Drivers

2.3.3 Kidney Cancer Market Challenges

2.3.4 Kidney Cancer Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Kidney Cancer by Players

3.1.1 Global Kidney Cancer Revenue by Players (2019-2024)

3.1.2 Global Kidney Cancer Revenue Market Share by Players (2019-2024)

3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Kidney Cancer, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Kidney Cancer Market Concentration Ratio

3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2023

3.5 Global Key Players of Kidney Cancer Head office and Area Served

3.6 Global Key Players of Kidney Cancer, Product and Application

3.7 Global Key Players of Kidney Cancer, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Kidney Cancer Breakdown Data by Type

4.1 Global Kidney Cancer Historic Market Size by Type (2019-2024)

4.2 Global Kidney Cancer Forecasted Market Size by Type (2025-2030)

5 Kidney Cancer Breakdown Data by Application

5.1 Global Kidney Cancer Historic Market Size by Application (2019-2024)

5.2 Global Kidney Cancer Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Kidney Cancer Market Size (2019-2030)

6.2 North America Kidney Cancer Market Size by Type

6.2.1 North America Kidney Cancer Market Size by Type (2019-2024)

6.2.2 North America Kidney Cancer Market Size by Type (2025-2030)

6.2.3 North America Kidney Cancer Market Share by Type (2019-2030)

6.3 North America Kidney Cancer Market Size by Application

6.3.1 North America Kidney Cancer Market Size by Application (2019-2024)

6.3.2 North America Kidney Cancer Market Size by Application (2025-2030)

6.3.3 North America Kidney Cancer Market Share by Application (2019-2030)

6.4 North America Kidney Cancer Market Size by Country

6.4.1 North America Kidney Cancer Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Kidney Cancer Market Size by Country (2019-2024)

6.4.3 North America Kidney Cancer Market Size by Country (2025-2030)

6.4.4 United States

6.4.5 Canada

7 Europe

7.1 Europe Kidney Cancer Market Size (2019-2030)

7.2 Europe Kidney Cancer Market Size by Type

7.2.1 Europe Kidney Cancer Market Size by Type (2019-2024)

7.2.2 Europe Kidney Cancer Market Size by Type (2025-2030)

7.2.3 Europe Kidney Cancer Market Share by Type (2019-2030)

7.3 Europe Kidney Cancer Market Size by Application

7.3.1 Europe Kidney Cancer Market Size by Application (2019-2024)

7.3.2 Europe Kidney Cancer Market Size by Application (2025-2030)

7.3.3 Europe Kidney Cancer Market Share by Application (2019-2030)

7.4 Europe Kidney Cancer Market Size by Country

7.4.1 Europe Kidney Cancer Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Kidney Cancer Market Size by Country (2019-2024)

7.4.3 Europe Kidney Cancer Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Kidney Cancer Market Size (2019-2030)

8.2 China Kidney Cancer Market Size by Type

8.2.1 China Kidney Cancer Market Size by Type (2019-2024)

8.2.2 China Kidney Cancer Market Size by Type (2025-2030)

8.2.3 China Kidney Cancer Market Share by Type (2019-2030)

8.3 China Kidney Cancer Market Size by Application

8.3.1 China Kidney Cancer Market Size by Application (2019-2024)

8.3.2 China Kidney Cancer Market Size by Application (2025-2030)

8.3.3 China Kidney Cancer Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Kidney Cancer Market Size (2019-2030)

9.2 Asia Kidney Cancer Market Size by Type

9.2.1 Asia Kidney Cancer Market Size by Type (2019-2024)

9.2.2 Asia Kidney Cancer Market Size by Type (2025-2030)

9.2.3 Asia Kidney Cancer Market Share by Type (2019-2030)

9.3 Asia Kidney Cancer Market Size by Application

9.3.1 Asia Kidney Cancer Market Size by Application (2019-2024)

9.3.2 Asia Kidney Cancer Market Size by Application (2025-2030)

9.3.3 Asia Kidney Cancer Market Share by Application (2019-2030)

9.4 Asia Kidney Cancer Market Size by Region

9.4.1 Asia Kidney Cancer Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Kidney Cancer Market Size by Region (2019-2024)

9.4.3 Asia Kidney Cancer Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Kidney Cancer Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type

10.2.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Kidney Cancer Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application

10.3.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Kidney Cancer Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country

10.4.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Merck

11.1.1 Merck Company Details

11.1.2 Merck Business Overview

11.1.3 Merck Kidney Cancer Introduction

11.1.4 Merck Revenue in Kidney Cancer Business (2019-2024)

11.1.5 Merck Recent Developments

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Kidney Cancer Introduction

11.2.4 Novartis Revenue in Kidney Cancer Business (2019-2024)

11.2.5 Novartis Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Kidney Cancer Introduction

11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Kidney Cancer Introduction

11.4.4 Pfizer Revenue in Kidney Cancer Business (2019-2024)

11.4.5 Pfizer Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Kidney Cancer Introduction

11.5.4 Roche Revenue in Kidney Cancer Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Kidney Cancer Introduction

11.6.4 Amgen Revenue in Kidney Cancer Business (2019-2024)

11.6.5 Amgen Recent Developments

11.7 Aveo Pharmaceuticals

11.7.1 Aveo Pharmaceuticals Company Details

11.7.2 Aveo Pharmaceuticals Business Overview

11.7.3 Aveo Pharmaceuticals Kidney Cancer Introduction

11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024)

11.7.5 Aveo Pharmaceuticals Recent Developments

11.8 Bayer

11.8.1 Bayer Company Details

11.8.2 Bayer Business Overview

11.8.3 Bayer Kidney Cancer Introduction

11.8.4 Bayer Revenue in Kidney Cancer Business (2019-2024)

11.8.5 Bayer Recent Developments

11.9 Exelixis

11.9.1 Exelixis Company Details

11.9.2 Exelixis Business Overview

11.9.3 Exelixis Kidney Cancer Introduction

11.9.4 Exelixis Revenue in Kidney Cancer Business (2019-2024)

11.9.5 Exelixis Recent Developments

11.10 Eisai

11.10.1 Eisai Company Details

11.10.2 Eisai Business Overview

11.10.3 Eisai Kidney Cancer Introduction

11.10.4 Eisai Revenue in Kidney Cancer Business (2019-2024)

11.10.5 Eisai Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Surgery

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Other

Table 6. Global Kidney Cancer Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Kidney Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Kidney Cancer Market Share by Region (2019-2024)

Table 10. Global Kidney Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Kidney Cancer Market Share by Region (2025-2030)

Table 12. Kidney Cancer Market Trends

Table 13. Kidney Cancer Market Drivers

Table 14. Kidney Cancer Market Challenges

Table 15. Kidney Cancer Market Restraints

Table 16. Global Kidney Cancer Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Kidney Cancer Revenue Share by Players (2019-2024)

Table 18. Global Top Kidney Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)

Table 19. Global Kidney Cancer Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Kidney Cancer, Headquarters and Area Served

Table 22. Global Key Players of Kidney Cancer, Product and Application

Table 23. Global Key Players of Kidney Cancer, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Kidney Cancer Revenue Market Share by Type (2019-2024)

Table 27. Global Kidney Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Kidney Cancer Revenue Market Share by Type (2025-2030)

Table 29. Global Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Kidney Cancer Revenue Share by Application (2019-2024)

Table 31. Global Kidney Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Kidney Cancer Revenue Share by Application (2025-2030)

Table 33. North America Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Kidney Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Kidney Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Kidney Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Kidney Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Kidney Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Kidney Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Kidney Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Kidney Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Kidney Cancer Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Kidney Cancer Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)

Table 65. Merck Company Details

Table 66. Merck Business Overview

Table 67. Merck Kidney Cancer Product

Table 68. Merck Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 69. Merck Recent Developments

Table 70. Novartis Company Details

Table 71. Novartis Business Overview

Table 72. Novartis Kidney Cancer Product

Table 73. Novartis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 74. Novartis Recent Developments

Table 75. Bristol-Myers Squibb Company Details

Table 76. Bristol-Myers Squibb Business Overview

Table 77. Bristol-Myers Squibb Kidney Cancer Product

Table 78. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 79. Bristol-Myers Squibb Recent Developments

Table 80. Pfizer Company Details

Table 81. Pfizer Business Overview

Table 82. Pfizer Kidney Cancer Product

Table 83. Pfizer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 84. Pfizer Recent Developments

Table 85. Roche Company Details

Table 86. Roche Business Overview

Table 87. Roche Kidney Cancer Product

Table 88. Roche Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 89. Roche Recent Developments

Table 90. Amgen Company Details

Table 91. Amgen Business Overview

Table 92. Amgen Kidney Cancer Product

Table 93. Amgen Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 94. Amgen Recent Developments

Table 95. Aveo Pharmaceuticals Company Details

Table 96. Aveo Pharmaceuticals Business Overview

Table 97. Aveo Pharmaceuticals Kidney Cancer Product

Table 98. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 99. Aveo Pharmaceuticals Recent Developments

Table 100. Bayer Company Details

Table 101. Bayer Business Overview

Table 102. Bayer Kidney Cancer Product

Table 103. Bayer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 104. Bayer Recent Developments

Table 105. Exelixis Company Details

Table 106. Exelixis Business Overview

Table 107. Exelixis Kidney Cancer Product

Table 108. Exelixis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 109. Exelixis Recent Developments

Table 110. Eisai Company Details

Table 111. Eisai Business Overview

Table 112. Eisai Kidney Cancer Product

Table 113. Eisai Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)

Table 114. Eisai Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Kidney Cancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Kidney Cancer Market Share by Type: 2023 VS 2030

Figure 3. Surgery Features

Figure 4. Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Other Features

Figure 7. Global Kidney Cancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Kidney Cancer Market Share by Application: 2023 VS 2030

Figure 9. Renal Cell Carcinoma Case Studies

Figure 10. Renal Pelvis Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Kidney Cancer Report Years Considered

Figure 13. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Kidney Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Kidney Cancer Market Share by Region: 2023 VS 2030

Figure 16. Global Kidney Cancer Market Share by Players in 2023

Figure 17. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2023

Figure 19. North America Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Kidney Cancer Market Share by Type (2019-2030)

Figure 21. North America Kidney Cancer Market Share by Application (2019-2030)

Figure 22. North America Kidney Cancer Market Share by Country (2019-2030)

Figure 23. United States Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Kidney Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Kidney Cancer Market Share by Type (2019-2030)

Figure 27. Europe Kidney Cancer Market Share by Application (2019-2030)

Figure 28. Europe Kidney Cancer Market Share by Country (2019-2030)

Figure 29. Germany Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Kidney Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Kidney Cancer Market Share by Type (2019-2030)

Figure 37. China Kidney Cancer Market Share by Application (2019-2030)

Figure 38. Asia Kidney Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Kidney Cancer Market Share by Type (2019-2030)

Figure 40. Asia Kidney Cancer Market Share by Application (2019-2030)

Figure 41. Asia Kidney Cancer Market Share by Region (2019-2030)

Figure 42. Japan Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Kidney Cancer Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Kidney Cancer Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Kidney Cancer Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Kidney Cancer Market Share by Country (2019-2030)

Figure 52. Brazil Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Merck Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 61. Pfizer Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 62. Roche Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 63. Amgen Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 64. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 65. Bayer Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 66. Exelixis Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 67. Eisai Revenue Growth Rate in Kidney Cancer Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-14C14333

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Cancer Diagnostic Test Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28P13808

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Gamma Knife Radiosurgery (GKRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29R14086

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Adult Malignant Glioma Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-12R14095

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Kidney Cancer Market Insights, Forecast to 2030

Published Date: August 2024

Report Code: QYRE-Auto-38R2107

Global Kidney Cancer Market Insights, Forecast to 2030

FEATURED COMPANIES

Kidney Cancer Market Size

Kidney Cancer Market

Scope of Kidney Cancer Market Report

Chapter Outline

FAQ for this report

How fast is Kidney Cancer Market growing?

What is the Kidney Cancer Market size in 2030?

What is the market share of major companies in Kidney Cancer Market?

What is the Kidney Cancer Market share by region?

What is the Kidney Cancer Market share by type?

What is the Kidney Cancer Market share by application?

Who are the main players in the Kidney Cancer Market report?

What are the Application segmentation covered in the Kidney Cancer Market report?

What are the Type segmentation covered in the Kidney Cancer Market report?

FEATURED COMPANIES

RELATED REPORTS